Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)

Thosaphol Limpijankit, Roxana Mehran, Gary S. Mintz, George Dangas, Alexandra J. Lansky, John Kao, Dale T. Ashby, Issam Moussa, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon, Paul S. Teirstein

Research output: Contribution to journalArticlepeer-review

Abstract

We report the long-term outcome of 225 patients who failed γ-brachytherapy for in-stent restenosis. Total adverse events, target vessel revascularization, and myocardial infarction were higher after repeat percutaneous coronary intervention versus coronary artery bypass grafting. Therefore, coronary artery bypass grafting may be the preferable first-line therapy in these patients until other therapies (i.e., drug-eluting stents) are available. Shorter time from brachytherapy to radiation failure and late thrombosis after brachytherapy were independent predictors of adverse events.

Original languageEnglish (US)
Pages (from-to)315-318
Number of pages4
JournalAmerican Journal of Cardiology
Volume92
Issue number3
DOIs
StatePublished - Aug 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)'. Together they form a unique fingerprint.

Cite this